Skip to content

Exactly how many new mums are on GLP-1s?

The Room

Hosted by Freya Bleathman, Georgia Allison and Rafa Husain

43m
Transcript

Original podcast

Summary

Written by a model from the transcript; not yet reviewed.

This episode of The Room features hosts Georgia Allison, Freya Blethman, and Rafa Husain diving into postpartum bodies and the rising prevalence of GLP-1 medications among new mothers. The hosts explore their personal histories with body image, contrasting childhood backgrounds shaped by Southeast Asian food culture and steroid treatments for medical conditions with modern pressures around bounce-back culture. They examine survey data revealing that nine percent of women two years postpartum use GLP-1s or diet pills, and forty-nine percent deliberately eat less than needed, debating whether these drugs represent a liberating medical tool or a symptom of society's intolerance for larger bodies.

  • Nine percent of women two years postpartum use GLP-1 medications or diet pills. 27:18
  • Forty-nine percent of women who had a baby in the last two years deliberately ate less than they felt they needed. 41:38
  • Breastfeeding does not automatically cause rapid weight loss, as the weight difference at twelve months is only about a kilo. 12:48

Chapters

  1. 0:10
    Podcast Launch Celebration

    Hosts introduce the show and celebrate the successful launch week.

  2. 5:58
    Sponsor Spotlight: Clearblue Ovulation Test

    Clearblue advertises its digital ovulation test and fertility support.

  3. 10:04
    Personal Body Image Histories

    Hosts share childhood and pregnancy experiences shaping their body perceptions.

  4. 12:12
    Genetics, Hormones, and Postpartum Weight

    Exploration of how genetics and hormonal changes affect postpartum weight retention.

  5. 30:06
    Online Prescriptions and Black Market Concerns

    Hosts warn about the risks of non-prescribed GLP-1s and online pharmacies.

  6. 31:55
    Medical Risks of High-Dose GLP-1s

    Discussion of potential side effects such as blindness and cardiovascular issues.

  7. 36:54
    Societal Pressure and Postpartum Body Expectations

    Hosts reflect on algorithmic feeding of fitness content and the pressure to 'bounce back'.

  8. 41:38
    Future Trends and Statistics

    Review of current GLP-1 usage stats and predictions for future increases.

  9. 42:42
    Closing and Call to Action

    Hosts thank listeners, provide contact info, and sign off.

Highlights

Quotes

  • “The name means abundance and prosperity in Arabic.”
    Rafa Husain · 4:33
  • “I think the use of GLP-1s societally has really ramped up.”
    Georgia Allison · 27:38
  • “I think that people don't like that someone who has gotten to this state because of greed or laziness, shouldn't be able to get the easy way out.”
    Freya Bleathman · 33:20
  • Clearblue 5:58–17:46
  • One Pass 24:52–26:26
  • Lululemon 43:11–43:36

About this episode

In today's episode: our hosts explore how many women are taking GLP-1 medications or diet pills in the first two years postpartum. Big thanks to Clearblue, here to help you better understand your cycle and identify your most fertile days with their Advanced Digital Ovulation Test. You can learn more about ovulation tests, or shop Clearblue now. Thank you also to Onepass, a membership program for Australia's favourite retailers that is all about saving you a bit of time and money. The Room is produced by Dimity Kirkwood, video produced by Scott Walton, edited by Eilish Gilligan and executive-produced by Lucy Hunt. Our social media team consists of Naima Fatema, and our partnerships managers are Tabitha Rachmat and Tahnee Malina. We're a new show, and the best way to support us is by clicking ‘follow’ on Apple and Spotify, and we're super grateful to anyone who leaves a five-star review while they're at it. Also! An old-fashioned 'Tell a Friend In Real Life' is equally appreciated. Follow us on Instagram and TikTok. Note: The views and opinions expressed in this episode are those of the hosts, and are not medical endorsements. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

0:00
43:22

7,822 words · 5 speakers

Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.

Topics

  • Steroids
  • GLP-1
  • Australia
  • Manjaro
  • Nephrotic syndrome
  • Postpartum bodies
  • Office Works
  • Wurundjeri land
  • Eli Lilly
  • Ozempic

Page updated · transcript and summary are machine-generated